Skip to main content

Table 2 Frequency of axial shortening (CARE values) at follow-ups of 12-, 1-, and 6- months

From: A retrospective study of cumulative absolute reduction in axial length after photobiomodulation therapy

 

N

CARE1

CARE2

CARE3

CARE4

Total at Month 12

66

41(62.10%)

32(48.50%)

21(31.80%)

8(12.10%)

Total at Month 1

45

42(93.3%)

28(62.20%)

12(26.70%)

1(2.20%)

P = value*

 

< 0.001*

< 0.001*

< 0.001*

< 0.001*

AGE

N

CARE1

CARE2

CARE3

CARE4

8

70

10 (22.7%)

8 (18.2%)

4 (7.6%)

0

9

58

13 (10.7%)

8 (6.6%)

3 (2.3%)

0

10

44

22 (18.6%)

10 (8.5%)

2 (1.6%)

0

11

22

37 (41.6%)

27 (30.3%)

3 (3.4%)

1(1.41%)

12

20

12 (60.0%)

10 (50.0%)

10(50.0%)

6(10.0%)

13

35

21 (60.0%)

14 (40.0%)

4 (11.4%)

3(8.6%)

P-value*

 

< 0.001*

< 0.001*

0.025*

0.385

Gender

N

CARE1

CARE2

CARE3

CARE4

Girls

193

60 (30.0%)

41 (20.5%)

14 (7.0%)

7(3.6%)

Boys

149

55 (23.5%)

35 (15.0%)

6 (2.6%)

9(6.0%)

P-value*

 

0.098

0.447

0.343

0.377

  1. *Bold indicates statistically significant